GeneDx Holdings Corp.
WGS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $305,450 | $202,566 | $234,694 | $212,195 |
| % Growth | 50.8% | -13.7% | 10.6% | – |
| Cost of Goods Sold | $111,053 | $112,560 | $261,444 | $228,797 |
| Gross Profit | $194,397 | $90,006 | -$26,750 | -$16,602 |
| % Margin | 63.6% | 44.4% | -11.4% | -7.8% |
| R&D Expenses | $45,722 | $58,266 | $86,203 | $105,162 |
| G&A Expenses | $101,110 | $133,755 | $216,167 | $205,988 |
| SG&A Expenses | $168,481 | $194,711 | $338,242 | $318,726 |
| Sales & Mktg Exp. | $67,371 | $60,956 | $122,075 | $112,738 |
| Other Operating Expenses | $3,407 | $17,625 | $216,457 | $5,659 |
| Operating Expenses | $217,610 | $270,602 | $640,902 | $429,547 |
| Operating Income | -$23,213 | -$180,596 | -$667,652 | -$446,149 |
| % Margin | -7.6% | -89.2% | -284.5% | -210.3% |
| Other Income/Exp. Net | -$29,416 | $3,903 | $69,620 | $200,759 |
| Pre-Tax Income | -$52,629 | -$176,693 | -$598,032 | -$245,390 |
| Tax Expense | -$343 | -$926 | -$49,052 | $0 |
| Net Income | -$52,286 | -$175,767 | -$548,980 | -$245,390 |
| % Margin | -17.1% | -86.8% | -233.9% | -115.6% |
| EPS | -1.94 | -7.23 | -53.63 | -74.93 |
| % Growth | 73.2% | 86.5% | 28.4% | – |
| EPS Diluted | -1.94 | -7.23 | -53.63 | -74.93 |
| Weighted Avg Shares Out | 26,891 | 24,312 | 10,237 | 3,275 |
| Weighted Avg Shares Out Dil | 26,891 | 24,312 | 10,237 | 3,275 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1,114 | $2,541 | $79 |
| Interest Expense | $3,032 | $0 | $3,207 | $2,835 |
| Depreciation & Amortization | $21,953 | $33,734 | $59,309 | $21,807 |
| EBITDA | -$1,260 | -$136,460 | -$398,198 | -$220,748 |
| % Margin | -0.4% | -67.4% | -169.7% | -104% |